Cavalier Jason (CIK 1883290) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-03). Recent activity: Sell LYRA (667 shares), Sell LYRA (769 shares), Sell LYRA (684 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-03 | Lyra Therapeutics, Inc. (LYRA) | Principal Financial Officer | Sell | 667 | $0 |
| 2026-01-08 | Lyra Therapeutics, Inc. (LYRA) | Chief Financial Officer | Sell | 769 | $2,584 |
| 2025-07-14 | Lyra Therapeutics, Inc. (LYRA) | Chief Financial Officer | Sell | 684 | $6,094 |
Source: SEC Form 4 filings · as of 2026-04-03